NEW YORK, Jan. 1, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of ADC Therapeutics SA ("ADC Therapeutics" or the "Company") (NYSE: ADCT). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. The...
Hence then, the article about investor alert pomerantz law firm investigates claims on behalf of investors of adc therapeutics sa adct was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADC Therapeutics SA - ADCT )
Also on site :
- Two dozen killed in Ukrainian strike on Russian New Year’s celebration – governor
- Volunteer in Iran’s Revolutionary Guard reportedly killed during widening protests
- Palestinian Mujahideen Movement Condemns Israeli Enemy& 039;s Prevention of International Organizations from Continuing Their Work